Metformin is the hidden key to IVF success
According to Dr. Emily Carter, Chief Specialist at the London Center for Reproductive Medicine, “In the ovarian microenvironment, metformin acts as a precision tuner, recalibrating insulin signaling and metabolic rhythms to play the perfect prelude to embryo attachment.” Insulin resistance: the hidden killer of fertility About 33% of women of childbearing age worldwide have insulin resistance – a metabolic disorder that silently undermines the molecular basis of fertility. A Harvard Medical School 2025 study found: Insulin resistance reduces egg mitochondrial function by 40 percentEndometrial tolerance gene expression is reduced by 53 percentClinical pregnancy rates are 28% lower than in metabolically normal individualsAnd the intervention of metformin is opening up a new path of hope for such patients. I. Molecular Mechanism of Action: A Fertility Revolution Beyond Glucose Reduction Metformin achieves triple precision regulation by activating the AMPK signaling pathway14: Oocyte energy optimization: boosting mitochondrial ATP production by 300% and correcting meiotic errorsAndrogen storm calming: inhibits ovarian P450c17α enzyme activity and reduces testosterone levels by 67Follicle synchronization breakthrough: regulate AMH/FoxO3 signaling axis to increase mature follicle rate up to 82 Discovered by a team from the University of Cambridge through laser confocal microscopy 28: Neovascularization: 45% increase in endometrial vascular density in the metformin group (VEGF/KDR pathway activation)Glycogen reserve: 3.2-fold elevation of glycogen deposition in glandular epithelial cells (enhanced GLUT4 translocation)Immune homeostasis: modulation of Th1/Th2 ratio from 5.8 to 1.3, reducing the risk of embryo rejectionTypical case: Emma O’Sullivan (32 years old, PCOS combined with insulin resistance) in Ireland, after three months of metformin pretreatment, the expression of endometrial tolerance gene HOXA10 was increased 4-fold, and high-quality blastocysts were obtained and pregnancy was successfully achieved. II.Four pillars of clinical benefit Metabolomics studies reveal17: Optimization of follicular fluid lactate/pyruvate ratio from 12.8 to 1.5 (threshold for ideal embryonic development)Oxidative stress marker 8-OHdG…